Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics of the study population

From: Hepatitis B associated with severe COVID-19: a nationwide cohort study in Sweden

 

COVID-19 without HBV

n = 847 822

COVID-19 and HBV

N=2902

COVID-19 and HBV without cirrhosis

n = 2805

COVID-19 and HBV with cirrhosis

n = 97

Age (years) Mean (SD)

44.3 (17.2)

46.2 (13.3)

45.7 (13.1)

58.6 (12.0)

Sex, No (%)

    

 Male

410 282 (48.4%)

1602 (54.9%)

1532 (54.7%)

70 (72.2%)

 Female

437 540 (51.6%)

1313 (45.1%)

1286 (45.3%)

27 (27.8%)

Vaccination prior to COVID-19, No (%)

    

 No

1 042 055 (98.9%)

Too few

2 775 (98.9%)

Too few

 Yes

9 179 (1.1%)

Too few

30 (1.1%)

Too few

Region of birth, no (%)

    

 Northern Europe

655 207 (77.3%)

326 (11.2%)

304 (10.8%)

22 (22.7%)

 Rest of Europe

37 301 (4.4%)

267 (9.2%)

257 (9.1%)

10 (10.3%)

 Asia

99 934 (11.8%)

1 401 (48.3%)

1 364 (48.5%)

37 (38.1%)

 Africa

16 732 (2.0%)

499 (17.2%)

481 (17.2%)

18 (18.6%)

 America

11 223 (1.2%)

12 (0.4%)

10 (0.3%)

2 (2.1%)

 Other/missing

27 425 (3.2%)

397 (13.7%)

389 (13.9%)

8 (8.2%)

wCCI (excl liver disease) No (%)

    

 0

792 838 (93.5%)

2392 (82.4%)

2334 (83.2%)

58 (59.8%)

 1–2

30 468 (3.6%)

339 (11.7%)

333 (11.9%)

5 (5.5%)

 3–4

8 108 (1.0%)

62 (2.1%)

55 (2.0%)

7 (7.2%)

 >=5

16 408 (1.9%)

109 (3.8%)

82 (2.9%)

27 (27.8%)

Level of education, No (%)

    

 <9 years

133 270 (15.7%)

870 (30.0%)

829 (29.6%)

41 (42.3%)

 10–12 years

369 765 (43.6%)

1 153 (39.7%)

1 122 (40.0%)

31 (32.0%)

 >12 years

325 070 (38.3%)

733 (25.3%)

715 (25.5%)

18 (18.6%)

 Missing

19 717 (2.3%)

146 (5.0%)

139 (5.0%)

7 (7.2%)

Income, No (%)

    

 Lowest

140 840 (16.6%)

1 099 (37.9%)

1 047 (37.3%)

52 (53.6%)

 Low

169 976 (20.0%)

715 (24.%)

698 (24.9%)

17 (17.5%)

 Middle

174 817 (20.6%)

495 (17.1%)

485 (17.3%)

10 (10.3%)

 High

176 063 (20.8%)

321 (11.1%)

311 (11.1%)

10 (10.3%)

 Highest

175 478 (20.7%)

215 (7.4%)

207 (7.4%)

8 (8.2%)

 Missing

10 648 (1.3%)

57 (2.0%)

57 (2.0%)

0

  1. Data are n (%) or mean (SD). Percentages are calculated as a proportion of the included study population. SD= standard deviation. OR=odds ratio. wCCI=weighted Charlson Comorbidity Index, excluding liver disease. Income is divided in quintiles where quintile 1 is the highest income, quintile 5 is the lowest income. HBV= chronic Hepatitis B virus infection